Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan

被引:18
|
作者
Kikuchi, Eiji [1 ]
Oya, Mototsugu [1 ]
机构
[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan
关键词
clinical management; nationwide survey; renal pelvic tumor; upper tract urothelial carcinoma; ureteral tumor; UPPER URINARY-TRACT; NEOADJUVANT CHEMOTHERAPY; NEPHROURETERECTOMY; ASSOCIATION; CARBOPLATIN; PREVENTION; GUIDELINES; ADJUVANT; TUMORS; TRIAL;
D O I
10.1093/jjco/hyw072
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: A comprehensive survey has not yet been conducted to investigate care patterns by urologists for the management of upper tract urothelial carcinoma. Methods: We conducted a nationwide survey for urologists treating upper tract urothelial carcinoma patients. The questionnaire was approved by the Japanese Urological Association and sent by mail in February 2014 to 1119 institutes in Japan. We identified 627 responders for this study. Results: Our survey demonstrated that ( i) the mean number of radical nephroureterectomy cases per institution in 2013 was 7.6, ( ii) the main detecting tool for upper tract urothelial carcinoma is contrast-enhanced computed tomography, ( iii) the need for ureteroscopic evaluations is highly dependent on voiding urine cytology results, ( iv) 67% of urologists always or often perform radical nephroureterectomy by laparoscopic surgery, ( v) more than half of the urologists do not aggressively perform lymph node dissection, ( vi) 75% of the urologists perform bladder cuff incision through an extravesical approach, ( vii) urologists perform kidney-sparing surgery following various indications, ( viii) 59% of the urologists always perform adjuvant systemic chemotherapy for high-risk upper tract urothelial carcinoma patients, ( ix) the combination of gemcitabine and cisplatin is the most frequent chemo-regimen for metastatic upper tract urothelial carcinoma, and gemcitabine and cisplatin with dose reductions is also the first choice even in patients with impaired renal function and ( x) 10.5% of urologists always or sometimes perform single intravesical chemotherapy immediately after radical nephroureterectomy. Conclusions: The management strategy for upper tract urothelial carcinoma has changed with the introduction of new devices and development of instruments. The lack of clear evidence for relatively uncommon upper tract urothelial carcinoma affects the consistency of its treatment strategies.
引用
收藏
页码:768 / 774
页数:7
相关论文
共 50 条
  • [1] PATTERNS OF LYMPHATIC METASTASES IN UPPER TRACT UROTHELIAL CARCINOMA
    Espiritu, Patrick
    Coleman, Jonathan
    Sfakianos, John
    Spiess, Philippe
    Matin, Surena
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E16 - E16
  • [2] Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada
    Metcalfe, Michael
    Kassouf, Wassim
    Rendon, Ricardo
    Bell, David
    Izawa, Jonathan
    Chin, Joseph
    Kapoor, Anil
    Matsumoto, Edward
    Lattouf, Jean-Baptiste
    Saad, Fred
    Lacombe, Louis
    Fradet, Yves
    Fairey, Adrian
    Jacobson, Niels-Eric
    Drachenberg, Darryl
    Cagiannos, Ilias
    So, Alan
    Black, Peter
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2012, 6 (06): : 455 - 462
  • [3] Advancements in the clinical management of upper tract urothelial carcinoma
    Taylor, Jacob
    Meng, Xiaosong
    Ghandour, Rashed
    Margulis, Vitaly
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (12) : 1051 - 1060
  • [4] Re: Regional Differences in Practice Patterns and Associated Outcomes for Upper Tract Urothelial Carcinoma in Canada
    Laguna, M. Pilar
    [J]. JOURNAL OF UROLOGY, 2013, 190 (01): : 61 - 61
  • [5] Patterns of recurrence after nephroureterectomy for upper tract urothelial carcinoma: A retrospective analysis to guide an Australian upper tract urothelial carcinoma registry
    Kealey, Joshua
    Davis, Ian
    Sengupta, Shomik
    [J]. BJU INTERNATIONAL, 2022, 129 : 58 - 59
  • [6] Upper tract urothelial carcinoma
    Linton, Kate D.
    Catto, James W. F.
    [J]. JOURNAL OF CLINICAL UROLOGY, 2013, 6 (05) : 272 - 279
  • [7] Upper tract urothelial carcinoma
    Jewett, MAS
    [J]. JOURNAL OF UROLOGY, 2006, 175 (01): : 12 - 13
  • [8] Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association
    Mori, Kazuyuki
    Hatakeyama, Shingo
    Enokida, Hideki
    Miyake, Hideaki
    Kikuchi, Eiji
    Nishiyama, Hiroyuki
    Ichikawa, Tomohiko
    Kamai, Takao
    Kaji, Yasushi
    Kume, Haruki
    Kondo, Tsunenori
    Matsuyama, Hideyasu
    Masumori, Naoya
    Kawauchi, Akihiro
    Takenaka, Atsushi
    Uemura, Hirotsugu
    Eto, Masatoshi
    Nonomura, Norio
    Fujii, Yasuhisa
    Hinotsu, Shiro
    Ohyama, Chikara
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (03) : 194 - 207
  • [9] Clinical registries in upper tract urothelial carcinoma: commitment to collaboration
    Zeng, Jiping
    Chipollini, Juan
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (07) : 1043 - 1044
  • [10] Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract
    Sung, Hyun Hwan
    Cho, Junhun
    Kwon, Ghee Young
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han-Yong
    Lee, Hyun Moo
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (01) : 49 - 54